跳至主要内容
临床试验/CTRI/2012/02/002454
CTRI/2012/02/002454已完成4 期

Comparison of immunogenicity of a 3 dose and a 5 dose schedule of oral rotavirus vaccine in south Indian infants

Christian Medical College0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • : Child <7 weeks attending Well Baby Clinic at CMC for routine EPI immunization
  • Born after a gestational period of 36-42 weeks with birth weight >=2 kg;
  • Father, mother or other legally acceptable representative (guardian) properly informed about the study and having signed the informed consent form (ICF) and available for follow up

排除标准

  • : Child not meeting criteria for routine EPI immunization
  • History of congenital abdominal disorders, intussusception, or abdominal surgery;
  • Known or suspected impairment of immunological function;
  • Known hypersensitivity to any component of the rotavirus vaccine;
  • Prior receipt of any rotavirus vaccine;
  • Fever, with axillary temperature >=38.1oC (>=100.5oF); measured by study staff.
  • History of known rotavirus disease, chronic diarrhea, or failure to thrive;
  • Clinical evidence of active gastrointestinal illness (infants with GERD can participate in the study so long as this condition is well controlled with or without medication);
  • Receipt of any IM, oral, or IV corticosteroid treatment in the past 30 days (infants on inhaled steroids may be permitted to participate in the study)

研究者

相似试验

进行中(未招募)
1 期
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and MexicoHealthy volunteers (meningococcal infection)MedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2017-004977-15-Outside-EU/EEASanofi Pasteur Inc525
进行中(未招募)
不适用
Trial to assess whether it is safe and efficient to vaccinate children with lower dose of Inactivated Poliovirus Vaccine (IPV) , Cuba 2017polio
ACTRN12617001525370WHO400
招募中
不适用
The comparison of Immune response to the 4th dose booster with mRNA-1273 COVID-19 vaccine in individuals who had received 2 doses of CoronaVac and booster with ChAdOx-1 or BNT162b2 COVID-19 vaccineBooster vaccination with mRNA 1273 COVID vaccine in individuals who had received 2 doses of CoronaVac and booster with BNT162b2 or ChAdOx-1 COVID vaccine.mRNA 1273 , booster, covid 19 vaccine, immunogenicity
TCTR20220205002Thammasat University Hospital100
进行中(未招募)
不适用
Safety and efficay of 3 new low dose polio vaccines with adjuvant compared to a full dose polio vaccine without adjuvantProfylactic immunisation against poliomyelitisMedDRA version: 17.0Level: LLTClassification code 10054187Term: Polio immunizationSystem Organ Class: 100000004865
EUCTR2014-000052-29-DKStatens Serum Institut
已完成
1 期
Comparison of Anti Pneumococcal Vaccinal Response in HIV-positive AdultsHIV infected patientsB04.820.650.589.650.350D20.215.894.135.750.600
RBR-3p7577Hospital das Clínicas da Faculdade de Medicina da USP